Stockscreener 앱 받기
60.53
1.56%
0.93
시간 외 거래:
60.53
전일 마감가:
$59.60
열려 있는:
$59.34
하루 거래량:
1.93M
Relative Volume:
2.38
시가총액:
$3.77B
수익:
$45.48M
순이익/손실:
$169.95M
주가수익비율:
23.10
EPS:
2.62
순현금흐름:
$230.85M
1주 성능:
+2.51%
1개월 성능:
+12.30%
6개월 성능:
+57.43%
1년 성능:
+44.05%
1일 변동 폭
$58.03
$61.04
1주일 범위
$57.45
$61.04
52주 변동 폭
$33.31
$61.89
Protagonist Therapeutics Inc Stock (PTGX) Company Profile
명칭
Protagonist Therapeutics Inc
전화
(510) 474-0170
주소
7707 GATEWAY BLVD., SUITE 140, NEWARK, CA
PTGX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PTGX
Protagonist Therapeutics Inc
|
60.53 | 3.71B | 45.48M | 169.95M | 230.85M | 2.62 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Protagonist Therapeutics Inc Stock (PTGX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-17 | 개시 | Citigroup | Buy |
| 2024-12-06 | 개시 | BMO Capital Markets | Outperform |
| 2024-12-06 | 개시 | Goldman | Neutral |
| 2024-11-05 | 개시 | Wedbush | Outperform |
| 2024-09-24 | 개시 | TD Cowen | Buy |
| 2024-09-09 | 개시 | Truist | Buy |
| 2023-10-30 | 개시 | CapitalOne | Overweight |
| 2023-05-25 | 재개 | Jefferies | Buy |
| 2022-08-25 | 개시 | JMP Securities | Mkt Outperform |
| 2022-02-11 | 개시 | BTIG Research | Buy |
| 2021-10-12 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-10-11 | 업그레이드 | Northland Capital | Market Perform → Outperform |
| 2021-09-20 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-05-24 | 개시 | JMP Securities | Mkt Outperform |
| 2021-05-24 | 개시 | Northland Capital | Outperform |
| 2021-01-06 | 개시 | JP Morgan | Overweight |
| 2020-12-16 | 개시 | Piper Sandler | Overweight |
| 2020-09-18 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-15 | 개시 | Jefferies | Buy |
| 2020-05-18 | 재확인 | H.C. Wainwright | Buy |
| 2019-07-08 | 개시 | H.C. Wainwright | Buy |
| 2019-05-09 | 업그레이드 | Stifel | Hold → Buy |
| 2018-12-06 | 개시 | Nomura | Buy |
| 2018-01-29 | 개시 | Stifel | Buy |
| 2017-07-21 | 개시 | BTIG Research | Buy |
모두보기
Protagonist Therapeutics Inc 주식(PTGX)의 최신 뉴스
Applying Wyckoff theory to Protagonist Therapeutics Inc. stock2025 Biggest Moves & Safe Swing Trade Setups - Newser
Is Protagonist Therapeutics Inc. a cyclical or defensive stock2025 Risk Factors & Real-Time Sentiment Analysis - خودرو بانک
What is Protagonist Therapeutics Inc. s revenue forecastJuly 2025 Short Interest & High Return Trade Guides - خودرو بانک
Institutional scanner results for Protagonist Therapeutics Inc.July 2025 Outlook & Community Supported Trade Ideas - Newser
Live market analysis of Protagonist Therapeutics Inc.Bull Run & Fast Momentum Entry Tips - Newser
What’s the recovery path for long term holders of Protagonist Therapeutics Inc.July 2025 Weekly Recap & High Accuracy Investment Signals - Newser
Will Protagonist Therapeutics Inc. benefit from geopolitical trendsMarket Sentiment Report & Real-Time Volume Spike Alerts - خودرو بانک
Can Protagonist Therapeutics Inc. expand into new markets2025 Fundamental Recap & Reliable Price Breakout Signals - خودرو بانک
Is Protagonist Therapeutics Inc. affected by consumer sentiment2025 Volume Leaders & AI Driven Stock Reports - خودرو بانک
Custom watchlist performance reports with Protagonist Therapeutics Inc.July 2025 Review & Reliable Momentum Entry Alerts - Newser
Can volume confirm reversal in Protagonist Therapeutics Inc.2025 Investor Takeaways & Risk Managed Trade Strategies - Newser
Will Protagonist Therapeutics Inc. benefit from rate cutsCPI Data & Technical Pattern Recognition Alerts - خودرو بانک
Is Protagonist Therapeutics Inc. vulnerable to short sellers2025 EndofYear Setup & Entry Point Confirmation Signals - خودرو بانک
Is Protagonist Therapeutics Inc. in a bullish channel2025 Support & Resistance & Consistent Profit Trading Strategies - خودرو بانک
How is Protagonist Therapeutics Inc. managing supply chain issues2025 Year in Review & Verified Momentum Stock Ideas - خودرو بانک
Using Ichimoku Cloud for Protagonist Therapeutics Inc. technicalsMarket Risk Report & Daily Stock Momentum Reports - Newser
Applying big data sentiment scoring on Protagonist Therapeutics Inc.Market Risk Analysis & Weekly High Potential Stock Alerts - Newser
Can Protagonist Therapeutics Inc. continue delivering strong returns2025 Pullback Review & AI Powered Buy/Sell Recommendations - khodrobank.com
What momentum shifts mean for Protagonist Therapeutics Inc.Weekly Trade Summary & Daily Volume Surge Signals - Newser
Comparing Protagonist Therapeutics Inc. in custom built stock radarsTrade Risk Report & Detailed Earnings Play Alerts - Newser
Will Protagonist Therapeutics Inc. stock go up soon2025 Support & Resistance & Risk Controlled Swing Alerts - Newser
Technical analysis overview for Protagonist Therapeutics Inc. stock2025 Price Momentum & Reliable Entry Point Trade Alerts - Newser
Published on: 2025-09-04 00:44:39 - Newser
What MACD signals say about Protagonist Therapeutics Inc.Earnings Overview Report & Reliable Entry Point Alerts - Newser
How to build a custom watchlist for Protagonist Therapeutics Inc.Portfolio Gains Summary & Accurate Trade Setup Notifications - Newser
Transcript : Protagonist Therapeutics, Inc. Presents at Citi's Biopharma Back to School Conference, Sep-03-2025 09 - MarketScreener
Real time social sentiment graph for Protagonist Therapeutics Inc.Earnings Overview Summary & Community Consensus Picks - Newser
Protagonist Therapeutics to Participate in Multiple Investment Bank Conferences in September 2025 - Democrat and Chronicle
What to do if you’re stuck in Protagonist Therapeutics Inc.2025 Retail Activity & Safe Capital Growth Tips - Newser
Protagonist Therapeutics Inc. stock trendline breakdownWeekly Volume Report & Step-by-Step Swing Trade Plans - Newser
Can Protagonist Therapeutics Inc. stock outperform in a bear marketJuly 2025 Volume & AI Driven Price Predictions - خودرو بانک
Can technical indicators confirm Protagonist Therapeutics Inc.’s reversal2025 Macro Impact & Fast Entry Momentum Alerts - Newser
Has Protagonist Therapeutics Inc. formed a bullish divergencePortfolio Return Summary & Precise Buy Zone Tips - Newser
Buyback Watch: Is Protagonist Therapeutics Inc. being accumulated by smart money2025 Historical Comparison & Fast Entry and Exit Trade Plans - خودرو بانک
Combining machine learning predictions for Protagonist Therapeutics Inc.2025 Earnings Impact & Fast Moving Stock Watchlists - Newser
Protagonist Therapeutics Inc. recovery potential after sell offQuarterly Earnings Summary & High Yield Equity Trading Tips - Newser
Analyzing drawdowns of Protagonist Therapeutics Inc. with statistical toolsEarnings Beat & Technical Buy Zone Confirmation - Newser
Protagonist Therapeutics Inc (PTGX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):